Plasma metabolites (Mannose and Threonate) are key mediators in the diet–kidney stone nexus, and the downregulation of LAMA2 and CSNK1G3 is associated with a decreased risk of kidney stones, providing insights into potential therapeutic targets. The gene discussed is CSNK1G3; the disease is nephrolithiasis.